Seeing Is Believing
Currently out of the existing stock ratings of James Lee, 400 are a BUY (72.2%), 15 are a SELL (2.71%), 139 are a HOLD (25.09%).
Analyst James Lee, currently employed at MIZUHO, carries an average stock price target met ratio of 60.01% that have a potential upside of 40.57% achieved within 166 days.
James Lee’s has documented 1,093 price targets and ratings displayed on 50 stocks. The coverage is on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.
Most recent stock forecast was given on TRVG, Trivago NV at 30-Sep-2025.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$151
$30.78 (25.60%)
$160
9 days ago
(29-Sep-2025)
14/16 (87.5%)
$29.58 (24.36%)
57
Sell
$104
$-16.22 (-13.49%)
$106
1 months 6 days ago
(02-Sep-2025)
4/6 (66.67%)
$-20.9 (-16.73%)
29
Buy
$160
$39.78 (33.09%)
$185
1 months 28 days ago
(10-Aug-2025)
7/12 (58.33%)
$41.7 (35.25%)
55
Sell
$105
$-15.22 (-12.66%)
$104
2 months 2 days ago
(06-Aug-2025)
0/3 (0%)
$-15.03 (-12.52%)
Sell
$120
$-0.22 (-0.18%)
$130
2 months 2 days ago
(06-Aug-2025)
19/24 (79.17%)
$-0.03 (-0.02%)
108
Which stock is James Lee is most bullish on?
Which stock is James Lee is most reserved on?
What Year was the first public recommendation made by James Lee?